NEOADJUVANT THERAPY
Clinical trials for NEOADJUVANT THERAPY explained in plain language.
Never miss a new study
Get alerted when new NEOADJUVANT THERAPY trials appear
Sign up with your email to follow new studies for NEOADJUVANT THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise in shrinking lung tumors before surgery
Disease control CompletedThis study tested whether adding the immunotherapy drug serplulimab to standard chemotherapy before and after surgery helps people with stage II-IIIA non-small cell lung cancer. 30 patients received the combination treatment. The main goal was to see how many had a major response…
Matched conditions: NEOADJUVANT THERAPY
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated May 26, 2026 08:29 UTC
-
Drug combo helps High-Risk kidney cancer patients avoid full kidney removal
Disease control CompletedThis study tested a combination of two drugs (cadonilimab and lenvatinib) given before surgery to 39 people with kidney cancer that was difficult to operate on. The goal was to shrink the tumor enough so that only the cancerous part of the kidney could be removed, sparing the res…
Matched conditions: NEOADJUVANT THERAPY
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 26, 2026 08:29 UTC
-
Chemo's toll on the body: new study measures strength and balance in breast cancer patients
Knowledge-focused CompletedThis study looked at how neoadjuvant chemotherapy (chemo given before surgery) affects physical abilities in 67 women with breast cancer. Researchers measured muscle strength, balance, and daily function before and after treatment. The goal was to understand the physical changes …
Matched conditions: NEOADJUVANT THERAPY
Sponsor: ATİYE KAŞ ÖZDEMİR • Aim: Knowledge-focused
Last updated May 26, 2026 08:40 UTC
-
Blood cell changes may forecast pancreatic cancer survival
Knowledge-focused CompletedThis study looked at 300 people with pancreatic cancer to see if changes in a specific type of tumor cell in the blood (called mesenchymal CTCs) could predict how well they respond to treatment before surgery. Researchers tracked these cells over time and compared them to surviva…
Matched conditions: NEOADJUVANT THERAPY
Sponsor: Guo ShiWei • Aim: Knowledge-focused
Last updated May 26, 2026 08:29 UTC